Apogee Therapeutics, Inc. Common Stock (APGE) Financials
Key financial figures for Apogee Therapeutics, Inc. Common Stock (Q2 2026).
- Revenue
- $0
- Net Income
- -$86M
- EPS
- $-1.14
- Total Assets
- $1.3B
- Operating Cash Flow
- -$71M
Full income statement, balance sheet, and cash flow for Apogee Therapeutics, Inc. Common Stock on SentiSense.